𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir

✍ Scribed by A. Ong; V. W.-S. Wong; G. L.-H. Wong; H.-Y. Chan; C.-H. Tse; H. L.-Y. Chan

Book ID
108606451
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
191 KB
Volume
34
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical course and predictive factors o
Clinical course and predictive factors of virological response in long-term lamivudine plus adefovir dipivoxil combination therapy for lamivudine-resistant chronic hepatitis B patients
✍ Mashu Aizawa; Akihito Tsubota; Kiyotaka Fujise; Keiko Tatsuzawa; Midori Kono; Sa πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 1 views

## Abstract The aims of this study were to assess the long‐term efficacy of lamivudine (LAM) plus adefovir dipivoxil (ADV) combination therapy in patients with chronic hepatitis B resistant to LAM, to identify predictive factors of complete viral response (HBV‐DNA <2.6 log copies/ml at 12 months of